Hypertension
Conditions
Keywords
Behavior Change, patient Education
Brief summary
To improve the quality of hypertension care in our facility, while concurrently, examining the relative contribution of each aspect of a multi-factorial intervention designed to improve hypertension care.
Detailed description
This project was a randomized trial designed to examine the relative contribution of three quality improvement interventions of increasing intensity on BP control in veterans. Providers in each stratum and their eligible patients were randomized to one of three study arms. The providers randomized to the first arm received education alone, and were considered the controls. Providers randomized to the second arm received both provider education and a hypertension alert. The third arm included provider education, a hypertension alert, and patient education. Patients were eligible for inclusion if they were aged 21- 90 years and filled their medications with the VA pharmacies. Between July and December 2003, we determined patient eligibility using a search strategy using data from the Mid South Quality Improvement Data warehouse, which is downloaded monthly from Veterans' Health Information System and Technology Architecture (VistA).
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Patients were eligible for inclusion if they were aged 21- 90 years and filled their medications with the VA pharmacies. Seen in 2003 and had a primary care visit coded as hypertension using International Classification of Diseases Ninth Revision; Clinical Modification (ICD 9-CM) (24) of 401.1 or 401.9 and who were prescribed only one antihypertensive medication
Exclusion criteria
More than one antihypertensive medication Refuse consent to review medical record Pregnant Prisoners
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reaching Systolic BP goal 6 months after intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Reaching Diastolic BP goal 6 months after intervention Any additional prescriptions of antihypertensive medications. | — |
Countries
United States